| Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 E Beghi, G Giussani, E Nichols, F Abd-Allah, J Abdela, A Abdelalim, ... The Lancet Neurology 18 (4), 357-375, 2019 | 666 | 2019 |
| Overlapping demyelinating syndromes and anti–N‐methyl‐D‐aspartate receptor encephalitis MJ Titulaer, R Höftberger, T Iizuka, F Leypoldt, L McCracken, T Cellucci, ... Annals of neurology 75 (3), 411-428, 2014 | 526 | 2014 |
| Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical … AC White Jr, CM Coyle, V Rajshekhar, G Singh, WA Hauser, A Mohanty, ... Clinical Infectious Diseases 66 (8), e49-e75, 2018 | 368 | 2018 |
| Revised diagnostic criteria for neurocysticercosis OH Del Brutto, TE Nash, AC White Jr, V Rajshekhar, PP Wilkins, G Singh, ... Journal of the Neurological Sciences 372, 202-210, 2017 | 298 | 2017 |
| Treatment of neurocysticercosis: current status and future research needs TE Nash, G Singh, AC White, V Rajshekhar, JA Loeb, JV Proano, ... Neurology 67 (7), 1120-1127, 2006 | 222 | 2006 |
| Keeping people with epilepsy safe during the COVID-19 pandemic JA French, MJ Brodie, R Caraballo, O Devinsky, D Ding, L Jehi, N Jette, ... Neurology 94 (23), 1032-1037, 2020 | 166 | 2020 |
| Cancer risk in people with epilepsy: the role of antiepileptic drugs G Singh, PH Driever, JW Sander Brain 128 (1), 7-17, 2005 | 136 | 2005 |
| From seizures to epilepsy and its substrates: N eurocysticercosis G Singh, JG Burneo, JW Sander Epilepsia 54 (5), 783-792, 2013 | 127 | 2013 |
| The global burden of epilepsy report: Implications for low-and middle-income countries G Singh, JW Sander Epilepsy & Behavior 105, 106949, 2020 | 124 | 2020 |
| A diagnostic and therapeutic scheme for a solitary cysticercus granuloma G Singh, V Rajshekhar, JMK Murthy, S Prabhakar, M Modi, N Khandelwal, ... Neurology 75 (24), 2236-2245, 2010 | 118 | 2010 |
| Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment G Singh, JH Rees, JW Sander Journal of Neurology, Neurosurgery & Psychiatry 78 (4), 342-349, 2007 | 114 | 2007 |
| Neurocysticercosos in South-Central America and the Indian subcontinent: a comparative evaluation G Singh Arquivos de neuro-psiquiatria 55, 349-356, 1997 | 108 | 1997 |
| Uncommon presentations of neurocysticercosis IMS Sawhney, G Singh, OP Lekhra, SN Mathuriya, PS Parihar, ... Journal of the neurological sciences 154 (1), 94-100, 1998 | 99 | 1998 |
| Neurology of acute organophosphate poisoning G Singh, D Khurana Neurology India 57 (2), 119-125, 2009 | 91 | 2009 |
| Neurocysticercosis: a natural human model of epileptogenesis TE Nash, S Mahanty, JA Loeb, WH Theodore, A Friedman, JW Sander, ... Epilepsia 56 (2), 177-183, 2015 | 87 | 2015 |
| Preliminary results of the global audit of treatment of refractory status epilepticus M Ferlisi, S Hocker, M Grade, E Trinka, S Shorvon, ISC of the StEp, ... Epilepsy & Behavior 49, 318-324, 2015 | 74 | 2015 |
| Neurophysiological monitoring of pharmacological manipulation in acute organophosphate (OP) poisoning. The effects of pralidoxime, magnesium sulphate and pancuronium G Singh, G Avasthi, D Khurana, J Whig, R Mahajan Electroencephalography and clinical neurophysiology 107 (2), 140-148, 1998 | 73 | 1998 |
| Drug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis WM Otte, M Singla, JW Sander, G Singh Neurology 80 (2), 152-162, 2013 | 67 | 2013 |
| Relationship of depression, disability, and quality of life in Parkinson's disease: A hospital-based case-control study MP Arun, S Bharath, PK Pal, G Singh Neurology India 59 (2), 185-189, 2011 | 66 | 2011 |
| Focal cortical–subcortical calcifications (FCSCs) and epilepsy in the Indian subcontinent G Singh, MS Sachdev, A Tirath, AK Gupta, G Avasthi Epilepsia 41 (6), 718-726, 2000 | 65 | 2000 |
